Advertisement
Home Tags Atrial Fibrillation

Tag: Atrial Fibrillation

Percutaneous and transcatheter patent foramen ovale (PFO) closure prevent recurrent stroke in adults with PFO and cryptogenic stroke

Closure of Patent Foramen Ovale Cuts Recurrent Stroke/TIA Risk

0
Reviews demonstrate reduction in recurrent stroke risk after percutaneous transcatheter PFO closure
Assessing change in the CHA2DS2-VASc score over time is more predictive of ischemic stroke in patients with atrial fibrillation than the baseline score

Follow-Up Delta CHA2DS2-VASc Score Better Predicts CVA in A-Fib

0
CHA2DS2-VASc score not static; most a-fib patients develop new risk factor before ischemic stroke
For patients undergoing catheter ablation for nonvalvular atrial fibrillation

Interruption of Apixaban Doesn’t Impact Bleeding in A-Fib

0
Similarly low rate of thromboembolic events with uninterrupted, minimally interrupted apixaban
The U.S. Preventive Services Task Force (USPSTF) has found that the current evidence is inadequate to assess the benefits and harms of screening with electrocardiogram for atrial fibrillation in older adults; and for low-risk adults

USPSTF Reviews Use of ECG for Preventing A-Fib, CVD Events

0
I statement for use of ECG in A-fib in seniors; D recommendation against ECG for reducing CVD risk
In-hospital mortality among patients with atrial fibrillation is higher in rural hospitals than in urban hospitals

In-Hospital Deaths in A-Fib Patients Higher in Rural Areas

0
Risk of death is 17 percent higher in rural versus urban hospitals
Cardiologist care is associated with a lower rate of death in patients with new-onset atrial fibrillation

Specialty Care Tied to Reduced Mortality in New-Onset A-Fib

0
Finding despite increased rates of hospitalizations and other cardiovascular outcomes
For patients with atrial fibrillation and prior cerebrovascular accident

Ablation Cuts Risk of Recurrent Stroke in Patients With A-Fib

0
Patients with AF with no ablation have increased five-year risk of CVA, death versus ablated patients
For patients with atrial fibrillation

NOACs Show Lower Risk of Adverse Renal Outcomes in A-Fib

0
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
In clinical practice

Outcomes for Atrial Fibrillation Similar With Dabigatran, Warfarin

0
Ischemic stroke, extracranial bleeding rates similar; lower risk of intracranial bleeding with dabigatran
Moderate alcohol consumption is associated with reduced risk of heart failure but not atrial fibrillation

Moderate Alcohol Consumption Tied to Lower Heart Failure Risk

0
But no link between alcohol intake, onset of atrial fibrillation over median of eight years' follow-up